136 related articles for article (PubMed ID: 35653070)
1. Prevalence and risk factors of barrett's esophagus in lynch syndrome.
Farha N; Lyu R; Liska D; Bhatt A; Macaron C; Burke CA
Fam Cancer; 2023 Jan; 22(1):55-60. PubMed ID: 35653070
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in the development of esophageal adenocarcinoma.
Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
[TBL] [Abstract][Full Text] [Related]
3. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.
Balasubramanian G; Singh M; Gupta N; Gaddam S; Giacchino M; Wani SB; Moloney B; Higbee AD; Rastogi A; Bansal A; Sharma P
Am J Gastroenterol; 2012 Nov; 107(11):1655-61. PubMed ID: 23032983
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus: prevalence and size of hiatal hernia.
Cameron AJ
Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
[TBL] [Abstract][Full Text] [Related]
6. LOW PREVALENCE OF BARRETT'S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL.
DE Carli DM; Araujo AF; Fagundes RB
Arq Gastroenterol; 2017 Dec; 54(4):305-307. PubMed ID: 28954045
[TBL] [Abstract][Full Text] [Related]
7. Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus.
Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
Dig Dis Sci; 2002 Feb; 47(2):256-64. PubMed ID: 11855539
[TBL] [Abstract][Full Text] [Related]
8. Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.
Farha N; Hrabe J; Sleiman J; Beard J; Lyu R; Bhatt A; Church J; Heald B; Liska D; Mankaney G; Milicia S; Silverman M; Kalady MF; Burke CA
Gastrointest Endosc; 2022 Jan; 95(1):105-114. PubMed ID: 34252420
[TBL] [Abstract][Full Text] [Related]
9. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
[TBL] [Abstract][Full Text] [Related]
10. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
11. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma.
Wennerström EC; Risques RA; Prunkard D; Giffen C; Corley DA; Murray LJ; Whiteman DC; Wu AH; Bernstein L; Ye W; Chow WH; Vaughan TL; Liao LM
Cancer Med; 2016 Sep; 5(9):2657-65. PubMed ID: 27384379
[TBL] [Abstract][Full Text] [Related]
13. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
14. Screening and surveillance for complications related to gastroesophageal reflux disease.
Spechler SJ
Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.
Gopal DV; Lieberman DA; Magaret N; Fennerty MB; Sampliner RE; Garewal HS; Falk GW; Faigel DO
Dig Dis Sci; 2003 Aug; 48(8):1537-41. PubMed ID: 12924649
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic Risk Factors in a Comparison of a Barrett Esophagus Registry (BarrettNET) and a Case-Control Population in Germany.
Schmidt M; Ankerst DP; Chen Y; Wiethaler M; Slotta-Huspenina J; Becker KF; Horstmann J; Kohlmayer F; Lehmann A; Linkohr B; Strauch K; Schmid RM; Quante AS; Quante M
Cancer Prev Res (Phila); 2020 Apr; 13(4):377-384. PubMed ID: 32066580
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
18. Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma.
Hammad TA; Thrift AP; El-Serag HB; Husain NS
Dig Dis Sci; 2019 Feb; 64(2):367-372. PubMed ID: 30370493
[TBL] [Abstract][Full Text] [Related]
19. Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population.
Eluri S; Reddy S; Ketchem CC; Tappata M; Nettles HG; Watts AE; Cotton CC; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2022 Nov; 117(11):1764-1771. PubMed ID: 35971219
[TBL] [Abstract][Full Text] [Related]
20. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.
Sarr MG; Hamilton SR; Marrone GC; Cameron JL
Am J Surg; 1985 Jan; 149(1):187-93. PubMed ID: 3966636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
